Dermatofibroma screening: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (6 intermediate revisions by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{Homa}} | {{CMG}};{{AE}}{{Homa}} | ||
==Overview== | |||
There is insufficient evidence to recommend routine [[screening]] for dermatofibroma. | |||
==Screening== | |||
There is insufficient evidence to recommend routine [[screening]] for dermatofibroma | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 21:18, 29 July 2020
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma screening On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma screening |
|
Risk calculators and risk factors for Dermatofibroma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for dermatofibroma.
Screening
There is insufficient evidence to recommend routine screening for dermatofibroma